3Wolfgang Sadée. Genomics and Drugs: Finding the Optimal Drug for the Right Patient[J] 1998,Pharmaceutical Research(7):959～963
二级参考文献40
1Ishikawa K, Katsuya T, Sato N, et al. No association between α-adducin 460 polymorphism and essential hypertension in a Japanese population.Am Hypertens, 1998,11 : 502.
2Kato N, Sugiyama T, et al. Lake of essociation between the α-adducin locus and essential hypertension in the Japanese population. Hypertension, 1998, 31:730.
3Kamitani A, Wong ZYH, Fraser R, et al. Human α-adducin gene, blood pressure, and sodium metabolism. Hypertension, 1998,32:138.
4Hingorani AD, Jia H, Stevens PA, et al. Renin-angiotensin syslem gesl epolymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens, 1995,13:1602.
5Dudley C, Keavney B,Casadei B, et al. Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of renin-angiotensin system genes. J Hypertens, 1996,14:259.
6Stavroulakis GA, Makris TK, Krespi PG, et al. Predicting response to chronic antihypertensive treatment with fosinopril: the role of angiotensinconverting enzyme gene polymorphism. Cardiovase Drugs Ther,2000,14:427.
7O'toole L, Stewart M, Padfield P, et al. Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on respponse to angiotensin-converting enzyme inhibitors in patients with heart failure. J Cardiovasc Pharmacol, 1998,32:988.
8Mondorf UF, Russ A, Wiese mann A, et al. Contribution of angioteasin Ⅰ converting enzyme gene polymorphism and angiotensinogen gene polymorphism to blood pressure regulation in essential hypertension. Am J Hypertens, 1998,11 : 174.
9Ueda S, Meredith PA, Morton JJ, et al. ACE(I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans. Circulation, 1998,98:2 148.
10Poch E, Gonzalez D, Giner V, et al. Molecular basis of salt sensitivity in human hypertension. Hypertension,2001,38:1 204.
